| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JACC.2014.08.045 |
| P698 | PubMed publication ID | 25456755 |
| P50 | author | Yasushi Ino | Q106559011 |
| Takashi Akasaka | Q106559016 | ||
| Takashi Kubo | Q106559025 | ||
| Takashi Yamano | Q106559027 | ||
| Yasutsugu Shiono | Q106559030 | ||
| P2093 | author name string | Atsushi Tanaka | |
| Satoshi Ueno | |||
| Tomoyuki Yamaguchi | |||
| Hironori Kitabata | |||
| Yuichi Ozaki | |||
| Makoto Orii | |||
| Yoshiki Matsuo | |||
| Shigeho Takarada | |||
| Takashi Tanimoto | |||
| Toshio Imanishi | |||
| Kenichi Komukai | |||
| Yasushi Okumoto | |||
| Kunihiro Shimamura | |||
| Hideharu Akagi | |||
| Hirata Kumiko | |||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| optical coherence tomography | Q899552 | ||
| P304 | page(s) | 2207-2217 | |
| P577 | publication date | 2014-11-24 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study. | |
| P478 | volume | 64 |
| Q52720025 | A Single Dose of Atorvastatin Applied Acutely after Spinal Cord Injury Suppresses Inflammation, Apoptosis, and Promotes Axon Outgrowth, Which Might Be Essential for Favorable Functional Outcome. |
| Q92280999 | A transcriptomic model to predict increase in fibrous cap thickness in response to high-dose statin treatment: Validation by serial intracoronary OCT imaging |
| Q37129796 | Atorvastatin activates autophagy and promotes neurological function recovery after spinal cord injury. |
| Q47230624 | Clinical Predictors for Lack of Favorable Vascular Response to Statin Therapy in Patients With Coronary Artery Disease: A Serial Optical Coherence Tomography Study |
| Q89798553 | Clinical imaging of cardiovascular inflammation |
| Q38880500 | Clinical relevance for lowering C-reactive protein with statins. |
| Q93024451 | Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial |
| Q35815442 | Effect of Statin Therapy on Fibrous Cap Thickness in Coronary Plaques Using Optical Coherence Tomography: A Systematic Review and Meta-Analysis |
| Q47286408 | Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry |
| Q37381114 | Evolution of nonculprit coronary atherosclerotic plaques assessed by serial virtual histology intravascular ultrasound in patients with ST-segment elevation myocardial infarction and chronic total occlusion |
| Q89567627 | High-density lipoprotein cholesterol as a therapeutic target for residual risk in patients with acute coronary syndrome |
| Q58088064 | Imaging as a surrogate marker of drug efficacy in cardiovascular disease |
| Q50079370 | Impact of malondialdehyde-modified low-density lipoprotein on coronary plaque vulnerability in patients not receiving lipid-lowering therapy: a whole coronary analysis with multislice-computed tomography |
| Q33689064 | Impact of statins therapy on morphological changes in lipid-rich plaques stratified by 10-Year framingham risk score: A serial optical coherence tomography study |
| Q64087515 | Intensive Lipid-Lowering Therapy Ameliorates Asymptomatic Intracranial Atherosclerosis |
| Q38665986 | Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment |
| Q38543810 | Intravascular ultrasound and optical coherence tomography imaging of coronary atherosclerosis |
| Q33567290 | Lipid Lowering Therapy to Modify Plaque Microstructures. |
| Q48011810 | Lipid-lowering therapy stabilizes the complexity of non-culprit plaques in human coronary artery: a quantitative assessment using OCT bright spot algorithm |
| Q42584356 | Management of Coronary Artery Calcium and Coronary CTA Findings. |
| Q91259885 | Matrix metalloproteinases in pro-atherosclerotic arterial remodeling |
| Q50126843 | Nonculprit Plaque Characteristics in Patients With Acute Coronary Syndrome Caused by Plaque Erosion vs Plaque Rupture: A 3-Vessel Optical Coherence Tomography Study |
| Q45937484 | Rationale and design of a randomized trial of apixaban vs warfarin to evaluate atherosclerotic calcification and vulnerable plaque progression. |
| Q38665263 | Reperfusion strategies in acute myocardial infarction and multivessel disease |
| Q92572609 | ST-segment elevation myocardial infarction |
| Q50891913 | Serial volumetric assessment of coronary fibroatheroma by optical frequency domain imaging: insights from the TROFI trial |
| Q26738584 | Stabilization of high-risk plaques |
| Q90887596 | Statin treatment reduces matrix degradation capacity of proinflammatory polarized macrophages |
| Q35726338 | The Effect of Statin Therapy on Coronary Plaque Composition Using Virtual Histology Intravascular Ultrasound: A Meta-Analysis |
| Q38705936 | The use of optical coherence tomography in acute coronary syndrome |
| Q58802097 | Therapeutic effects of different Atorvastatin doses on vulnerable plaques in coronary arteries assessed by intracoronary optical coherence tomography |
| Q26738588 | Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies |
| Q42578211 | Three-dimensional morphological response of lipid-rich coronary plaques to statin therapy: a serial optical coherence tomography study |
| Q64058653 | Toll-Like Receptor 9 Plays a Pivotal Role in Angiotensin II-Induced Atherosclerosis |
Search more.